Prolacta Bioscience
Dedicated to improving the quality of life for the most fragile infants with 100% human milk-based nutrition.
Launch date
Employees
Market cap
-
Enterprise valuation
€32—49m (Dealroom.co estimates May 2018.)
Industry California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $810k | Series A | |
$540k | Series B | ||
$12.0m | Series C | ||
$5.8m | Early VC | ||
$15.0m | Series D | ||
$35.0m | Late VC | ||
| N/A | $8.9m | Early VC | |
| Total Funding | €71.0m | ||
Related Content
Recent News about Prolacta Bioscience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.